Lindbrook Capital LLC Acquires 790 Shares of Centene Co. (NYSE:CNC)

Lindbrook Capital LLC lifted its position in shares of Centene Co. (NYSE:CNC) by 24.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 3,999 shares of the company’s stock after buying an additional 790 shares during the period. Lindbrook Capital LLC’s holdings in Centene were worth $297,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Operose Advisors LLC acquired a new position in Centene during the 3rd quarter worth approximately $25,000. Turtle Creek Wealth Advisors LLC acquired a new position in Centene during the 4th quarter worth approximately $25,000. OFI Invest Asset Management acquired a new position in Centene during the 3rd quarter worth approximately $26,000. Headinvest LLC acquired a new position in Centene during the 3rd quarter worth approximately $35,000. Finally, Provence Wealth Management Group acquired a new position in Centene during the 3rd quarter worth approximately $44,000. Institutional investors own 93.63% of the company’s stock.

Insider Activity

In related news, Director Lori Jean Robinson sold 10,000 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total transaction of $774,100.00. Following the transaction, the director now directly owns 11,455 shares in the company, valued at $886,731.55. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Centene news, Director Lori Jean Robinson sold 10,000 shares of Centene stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the sale, the director now owns 11,455 shares of the company’s stock, valued at $886,731.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Kenneth J. Fasola sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the completion of the sale, the president now directly owns 235,365 shares in the company, valued at approximately $17,668,850.55. The disclosure for this sale can be found here. Corporate insiders own 0.29% of the company’s stock.

Centene Trading Up 0.6 %

NYSE:CNC opened at $75.59 on Tuesday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $40.43 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 0.93 and a beta of 0.38. The firm has a fifty day simple moving average of $76.51 and a two-hundred day simple moving average of $74.70. Centene Co. has a 12 month low of $60.83 and a 12 month high of $81.42.

Centene (NYSE:CNC) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $39.46 billion during the quarter, compared to analysts’ expectations of $36.16 billion. Centene had a net margin of 1.75% and a return on equity of 14.26%. The business’s revenue was up 11.0% on a year-over-year basis. During the same period last year, the company earned $0.86 earnings per share. Analysts expect that Centene Co. will post 6.75 EPS for the current fiscal year.

Analyst Ratings Changes

CNC has been the subject of several recent research reports. Cantor Fitzgerald restated an “overweight” rating and issued a $90.00 price target on shares of Centene in a research report on Thursday, April 4th. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 28th. Stephens restated an “equal weight” rating and issued a $85.00 price target (down from $92.00) on shares of Centene in a research report on Thursday, March 21st. Wells Fargo & Company upped their price target on shares of Centene from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Finally, Barclays assumed coverage on shares of Centene in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $101.00 price target for the company. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, Centene currently has a consensus rating of “Moderate Buy” and a consensus target price of $85.38.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.